Pathologic Gleason score (1.0), LVI (0.2836), and preoperative PSA level (0.1502) were found to be the three most important clinicopathologic factors in determining the risk of BCR in the patients with pT3 N0 prostate cancer. Here, KLK3 is linked to prostate carcinoma.